Cargando…
Development of A Neonatal Mouse Model for Coxsackievirus B1 Antiviral Evaluation
Coxsackievirus B1 (CVB1) is a leading causative agent of severe infectious diseases in humans and has been reported to be associated with outbreaks of aseptic meningitis, myocarditis, and the development of chronic diseases such as type 1 diabetes mellitus (T1DM). There is no approved vaccine or eff...
Autores principales: | Yin, Zhichao, Wu, Yuanyuan, Zhu, Rui, Xu, Longfa, Lin, Yu, Yang, Hongwei, Fu, Wenkun, Huang, Qiongzi, Zhang, Dongqing, Wang, Jue, Wang, Wei, Wang, Yingbin, Cheng, Tong, Xia, Ningshao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476979/ https://www.ncbi.nlm.nih.gov/pubmed/34581960 http://dx.doi.org/10.1007/s12250-021-00444-1 |
Ejemplares similares
-
Development of a rapid neutralization testing system for Rhinovirus C15 based on the enzyme-linked immunospot assay
por: Zhou, Zhenhong, et al.
Publicado: (2022) -
Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10
por: Zhu, Rui, et al.
Publicado: (2018) -
Antiviral Effects of Menthol on Coxsackievirus B
por: Taylor, David J.R., et al.
Publicado: (2020) -
Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody
por: Xu, Longfa, et al.
Publicado: (2017) -
Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines
por: Lin, Yanzhen, et al.
Publicado: (2018)